To experimentally investigate the potential role of STAMBPL1 in the EMT process, we used the lung adenocarcinoma (A549, NCI-H838) and breast carcinoma (MCF7, SUM159) cell lines, displaying either epithelial or mesenchymal traits, respectively. Here, STAMBPL1 is linked to breast carcinoma.